|
🐜
|
Effectiveness of a multimodal intervention in functionally impaired older people with type 2 diabetes mellitus
22 auth.
L. Rodríguez-Mañas,
O. Laosa,
B. Vellas,
G. Paolisso,
E. Topinkova,
J. Oliva-Moreno,
I. Bourdel-Marchasson,
M. Izquierdo,
Kerry Hood,
A. Zeyfang,
...
G. Gambassi,
M. Petrovic,
T. Hardman,
M. Kelson,
I. Bautmans,
G. Abellan,
M. Barbieri,
L. M. Peña-Longobardo,
S. Regueme,
R. Calvani,
Stefanie L. De Buyser,
A. Sinclair
|
6 |
2019 |
6
🐜
|
|
🐢
|
Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK)
36 auth.
L. Heaney,
R. Djukanović,
A. Woodcock,
S. Walker,
J. Matthews,
I. Pavord,
P. Bradding,
R. Niven,
C. Brightling,
R. Chaudhuri,
J. Arron,
D. Choy,
D. Cowan,
A. Mansur,
A. Menzies-Gow,
...
I. Adcock,
K. Chung,
C. Corrigan,
P. Coyle,
T. Harrison,
S. Johnston,
P. Howarth,
J. Lordan,
I. Sabroe,
J. Bigler,
Dirk E. Smith,
M. Catley,
R. May,
L. Pierre,
C. Stevenson,
G. Crater,
F. Keane,
R. Costello,
V. Hudson,
D. Supple,
T. Hardman
|
6 |
2015 |
6
🐢
|
|
🐜
|
Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial
50 auth.
L. Heaney,
J. Busby,
C. Hanratty,
R. Djukanović,
A. Woodcock,
S. Walker,
T. Hardman,
J. Arron,
D. Choy,
P. Bradding,
C. Brightling,
R. Chaudhuri,
D. Cowan,
A. Mansur,
S. Fowler,
...
R. Niven,
P. Howarth,
J. Lordan,
A. Menzies-Gow,
T. Harrison,
D. Robinson,
C. Holweg,
J. Matthews,
I. Pavord,
I. Adcock,
A. Azim,
M. Bellamy,
C. Borg,
M. Bourne,
C. Connolly,
R. Costello,
C. Corrigan,
Sarah E. Davies,
G. Davies,
K. Chung,
Gabrielle Gainsborough,
T. Grandison,
B. Hargadon,
Avril Horn,
V. Hudson,
D. Jackson,
S. Johnston,
G. Jones,
Paula McCourt,
María Nuñez,
D. Shaw,
Katherine Smith,
Joel Solis,
R. Stone,
Freda Yang
|
6 |
2020 |
6
🐜
|
|
🐜
|
An evaluation of the effectiveness of a multi-modal intervention in frail and pre-frail older people with type 2 diabetes - the MID-Frail study: study protocol for a randomised controlled trial
8 auth.
L. Rodríguez-Mañas,
A. Bayer,
M. Kelly,
A. Zeyfang,
M. Izquierdo,
O. Laosa,
...
T. Hardman,
A. Sinclair
|
6 |
2014 |
6
🐜
|
|
🐬
|
New lipid‐lowering drugs: an update
A. Wierzbicki,
T. Hardman,
A. Viljoen
|
5 |
2012 |
5
🐬
|
|
🦁
|
Development and potential role of type-2 sodium-glucose transporter inhibitors for management of type 2 diabetes
T. Hardman,
S. Dubrey
|
5 |
2011 |
5
🦁
|
|
🐬
|
Sarcoidosis: the links between epidemiology and aetiology
S. Dubrey,
Shreena Shah,
T. Hardman,
Rakesh Sharma
|
5 |
2014 |
5
🐬
|
|
🦁
|
Controversies surrounding erythrocyte sodium-lithium countertransport
T. Hardman,
A. Lant
|
5 |
1996 |
5
🦁
|
|
🐬
|
HIV lipodystrophy and its metabolic consequences: implications for clinical practice
A. Wierzbicki,
S. Purdon,
T. Hardman,
R. Kulasegaram,
B. Peters
|
5 |
2008 |
5
🐬
|
